Can a single platform predict your risk for multiple chronic diseases?

NCT ID NCT07727915

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This pilot study is testing whether the ADEN platform can accurately identify people at risk for heart disease, respiratory problems, cancer, autoimmune conditions, and frailty. Researchers will compare the platform's risk ratings to those made by doctors. If it works, the platform could become a tool for early detection and prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, the ADEN platform could provide a non-invasive way to detect early risk for multiple chronic diseases, enabling earlier interventions.
What could go wrong
This is a small pilot study (120 participants) focused on agreement with clinical assessment, not on health outcomes. The platform may not generalize beyond the Colombian population or meet the predefined success threshold.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UNIGEM

    Medellín, Antioquia, 050021, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.